Pharmacoepidemiology: Principles and Practice
McGraw-Hill, 2001 - Pharmacoepidemiology - 209 pages
Pharmacoepidemiology continues to be a growing area of study in the PharmD pharmacy curriculum. What exactly is pharmacoepidemiology? It is the study of the nature and extent of drug taking behaviours. With its basis in epidemiology, it measures source diffusion, and use of drugs in population. This discipline is currently focusing on pharmaceutical care outcomes and the identification of potential or real drug use problems. Adapted from the author's self-paced learning modules at MCP, this title is designed to aid the practising pharmacist or pharmacy student in developing and using concepts and methods for assessing the nature and extent of these drug taking behaviours.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Medical Surveillance and Outbreaks of Disease
Observational Study Designs in Epidemiology
9 other sections not shown
adverse drug reaction albuterol analysis analyze antibiotic assess associated asthma attack rate attributable risk calculated as follows cancer case-control study causative agent cohort study compared condition conducted confidence interval confounding variable cost-effectiveness critical value cumulative incidence data collected database death defined determine diagnosed discount disease who test drug therapy drug use problems effects epidemic epidemiology equal evaluating example experimental exposed frequencies identify incidence rate incubation period investigator involves mean measure median methods monitor mortality rate negative normal distribution null hypothesis Number of women occur odds ratio outbreak p-value period prevalence person-time units person-years pharmacists pharmacoeconomical pharmacoeconomical studies pharmacoepidemiology pharmacy placebo placebo group population predictive value prevalence proportion public health relationship relative risk risk estimate risk factor sample screening skewed specific spontaneous reporting statistically significant study design study results surveillance symptoms t-test thalidomide tion total number tryptophan unexposed users validity